Form 4 for XERS Xeris Biopharma Holdings, Inc.
Accepted 2026-01-09 00:00:00 ET · period of report 2026-01-08 · accession 0002031695-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-09 | 2026-01-08 | XERS | McCulloch Kevin | See Remarks | S - Sale | $8.00 | -15.0K | 1.69M | -0.9% | -$120.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-08 | S | D | 15,000 | $8.00 | 1,685,426 | D | — | — |